“It’s not just what you do, it’s how you do it: Variation in substance use screening outcomes with commonly used screening approaches in primary care clinics”, in AMERSA 43rd Annual National Conference, Boston, MA, 2019.
, “Kinematic risky driving behavior among younger and older drivers: Differences over time by age group and sex.”, Traffic Inj Prev, vol. 20, no. 7, pp. 708-712, 2019.
, “Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.”, Vaccine, vol. 37, no. 14, pp. 1978-1986, 2019.
, “LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.”, Retina, vol. 39, no. 9, pp. 1802-1809, 2019.
, “Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.”, J Empir Res Hum Res Ethics, vol. 14, no. 2, pp. 95-106, 2019.
, “Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.”, Vaccine, vol. 37, no. 30, pp. 4008-4014, 2019.
, “Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.”, Vaccine, vol. 37, no. 30, pp. 4001-4007, 2019.
, “Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.”, JAMA Ophthalmol, vol. 137, no. 3, pp. 281-287, 2019.
, , “Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.”, J Allergy Clin Immunol, vol. 143, no. 2, pp. 651-661.e9, 2019.
, “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
, “The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations”, in The National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity and Diagnostic Recommendations., Baltimore, MD, 2019.
, , , “The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.”, Leuk Lymphoma, vol. 60, no. 13, pp. 3161-3171, 2019.
, “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, vol. 126, no. 2, pp. 261-273, 2019.
, “Networks of face-to-face social contacts in Niakhar, Senegal.”, PLoS One, vol. 14, no. 8, p. e0220443, 2019.
, , “No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study.”, Clin Exp Ophthalmol, vol. 47, no. 1, pp. 63-68, 2019.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
, “Novel Microbial-Based Immunotherapy Approach for Crohn's Disease.”, Front Med (Lausanne), vol. 6, p. 170, 2019.
, “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.”, Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
, “Partnering, Not Enduring: Citizen Science and Research Participation.”, Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
, , “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.”, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
,